Clermont-Ferrand, France

Bettina Aboab

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Blaise Pascal - Clermont-Ferrand Ii. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bettina Aboab. Retrieved from https://idiyas.com/inventor/bettina-aboab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bettina Aboab: Innovator in Pharmaceutical Research

Introduction

Bettina Aboab is a notable inventor based in Clermont-Ferrand, France. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative research and development of chemical compounds.

Latest Patents

Bettina Aboab holds one patent related to pyrrolo[2,3-a]carbazole derivatives. This invention encompasses a method for preparing these derivatives and their application as PIM kinase inhibitors. The potential uses of her invention are particularly relevant in the pharmaceutical field, showcasing her impact on medical research.

Career Highlights

Throughout her career, Bettina has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Blaise Pascal - Clermont-Ferrand II. Her work in these organizations has allowed her to advance her research and collaborate with other experts in her field.

Collaborations

Bettina has collaborated with notable colleagues, including Fabrice Anizon and Pascale Moreau. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Bettina Aboab is a distinguished inventor whose work in pharmaceutical research has the potential to make a significant impact on medical treatments. Her innovative approach to developing new chemical compounds highlights her dedication to advancing science and improving healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…